Therefore, the identification and classification of PI3K/AKT/mTOR signaling pathway activation is closely related to the breast cancer subtypes [11], because it is susceptible to potential drug interventions, which selectively target tumors while leaving normal tissue alive [12,13]. This evidence concerns the gene MTOR and breast carcinoma.